Market Herald logo


Be the first with the news that moves the market

Analytica has announced the PeriCoach system is CE-Marked to assist in the treatment of Pelvic Organ Prolapse and urinary incontinence.

Currently, the only smartphone pelvic floor muscle rehabilitation system, PeriCoach helps more than 50 per cent of women who experience POP.

POP often occurs after women experience childbirth and their pelvic floor muscles become stretched leaving other organs, such as the bladder, feeling less supported.

PeriCoach consists of a pelvic floor training sensor, which is inserted and squeezed. This information is then connected and sent to an app on smart-phones.

This monitors activity in the pelvic floor muscles with the information then being sent to physicians to determine if the patient is doing the pelvic exercises.

These exercises will reduce the chance of surgery and improve health in the future.

Pelvic muscle exercises can also help with bladder leakage while pregnant and after you have given birth.

Other ways it helps include easier childbirth, reduction in back pain and reduced risk of health problems when you age.

PeriCoach can now be sold in Turkey, Switzerland and the surrounding European Area while already being available in Australia, New Zealand, UK, Ireland, and the USA.

Please find the announcement here

ALT by the numbers
More From The Market Herald
Appen (ASX:APX)-CEO, Mark Brayan (left)

" Appen (ASX:APX) feels ad-related impacts and buys Quadrant

Appen (ASX:APX) reports half-year results and plans to buy location data provider Quadrant for US$25 million…

" Appen (ASX:APX) downgrades earnings guidance as growth stutters

Machine learning and AI specialist Appen (ASX:APX) has downgraded its 2020 earnings guidance due to the…
Appen (ASX:APX) - CEO, Mark Brayan

" Appen (ASX:APX) invests in synthetic data business Mindtech

Appen (APX) has invested £2 million (A$3.6 million) in synthetic data company, Mindtech Global.

" Anatara Lifesciences (ASX:ANR) expands eligibility criteria for IBS and psychological functioning trials

Anatara Lifesciences (ASX:ANR) has received ethics approval to expand eligibility criteria for its Irritable Bowel Syndrome…